Cassava Sciences (SAVA) tumbles with several halts after DoJ announces "Professor Charged for Operating Multimillion-Dollar Grant Fraud Scheme"
SourceNewsquawk
SectionUS Equities
- "Hoau-Yan Wang, 67, was a tenured medical professor at a public university’s medical school, as well as a paid advisor and consultant to a publicly traded Texas biopharmaceutical company. From approximately May 2015 through approximately April 2023, Wang allegedly engaged in a scheme to fabricate and falsify scientific data in grant applications made to the NIH on behalf of himself and the biopharmaceutical company"
- Hoau-Yan Wang is the co-developer of Cassava's potential Alzheimer's drug.
Related Links
via DoJ